Skip to main content
Premium Trial:

Request an Annual Quote


Direct-to-consumer genetic testing services took one of the many spotlights at this year's American Society of Human Genetics meeting held in Washington, DC Science Insider recaps a talk from the Cleveland Clinic's Charis Eng, in which the geneticist expressed worry that patients who take DTC cancer screens "could be falsely reassured of falsely alarmed." The New Scientist highlights the Genetics and Public Policy Center's David Kaufman's presentation, in which he surveyed more than 1,000 customers from three DTC firms in order to assess whether they'd changed their behavior between two and six months after receiving their results. Kaufman found that 34 percent of respondents indicated that they'd become more vigilant about their dietary choices, 14 percent had increased their exercise, and 16 percent said they'd changed their medications, according to the magazine. "We don't give people enough credit to people's abilities to decide what's useful to them. ... People who get their data are generally pleased with it, and they respond in generally positive ways," Kaufman said at the meeting. Our sister publication GenomeWeb Daily News has more DTC discussion coverage from ASHG, here.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.